Genentech Oncology

THIS WEBSITE IS INTENDED FOR US HEALTHCARE PROFESSIONALS ONLY

Genentech Oncology logo
  • Registration
Search Menu Close
  • Home Page
  • Biomarker Testing
    • Breast
    • Gastrointestinal
    • Lung
    • Pan Tumor
  • Development Platforms
    • Antibody drug conjugates
    • iNeST
    • Monoclonal antibodies
    • Small molecules
    • Bispecific antibodies
  • Molecular Pathways
    • Cancer Target Overview
      • ALK
      • BCL-2
      • CD79b
      • HER Pathways
      • MAPK
      • MDM2
      • NTRK Gene Fusions
      • PI3K/AKT Pathway
      • Explore ROS1
      • VEGF
      • The Hallmarks of Cancer
    • Immune Target Overview
      • CD20 CD3
      • CEA CD3
      • PD-L1 Pathway
      • Immunity Phenotypes & Cycle
  • Investigational Therapies
  • Clinical Trials
  • Resources
  • Registration
  • Home
  • Site Map
  • Home Page
  • Biomarker Testing
    • Breast
    • Gastrointestinal
    • Lung
    • Pan Tumor
  • Development Platforms
    • Antibody drug conjugates
    • iNeST
    • Monoclonal antibodies
    • Small molecules
    • Bispecific antibodies
  • Molecular Pathways
    • Cancer Target Overview
      • ALK
      • BCL-2
      • CD79b
      • HER Pathways
      • MAPK
      • MDM2
      • NTRK Gene Fusions
      • PI3K/AKT Pathway
      • Explore ROS1
      • VEGF
      • The Hallmarks of Cancer
    • Immune Target Overview
      • CD20 CD3
      • CEA CD3
      • PD-L1 Pathway
      • Immunity Phenotypes & Cycle
  • Investigational Therapies
    • Ipatasertib Results
    • Mosunetuzumab Results
    • glofitamab Results
    • Atezolizumab (anti-PDL1 MAb)
    • CD19x4-1BBL
    • Venetoclax (BCL-2 inhibitor)
    • Simlukafusp alfa (FAP x IL2v)
    • HER2 x CD3
    • iNeST
    • Cevostamab
    • PD-1 x TIM3
    • SERD (3)
    • Tiragolumab (anti-TIGIT)
    • GDC-0077
    • IL15/IL15Ra-Fc
    • Cibisatamab (CEA x CD3)
    • TLR7 agonist (4)
    • PD-1 x IL2v
    • PD-1 x LAG3
    • CD25 MAb
    • BCMA x CD16a
    • KRAS G12C
    • New Molecular Entity
    • Pralsetinib (RET inhibitor)
  • Clinical Trials
  • Resources
  • Registration
  • Contact Us
  • Copyright
  • Search
  • About Us
Genentech Logo
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • Site Map
  • Copyright
  • Cookie Preferences

© 2021 Genentech USA, Inc. All rights reserved. This site is intended for U.S. Residents only.

Link to Healthcare Professionals Site
Close

The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.

Cancel OK
Link to Third Party Site
Close

The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.

Cancel OK